Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: An international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial

Karin S. Khuenl-Brady, Friedrich K. Pühringer, Christopher Rex, Andreas W. Sielenkämper, Casper Claudius, Per Bo Larsen, Martine E. Prins, Matthias Eikermann

Research output: Contribution to journalArticlepeer-review

197 Scopus citations

Fingerprint

Dive into the research topics of 'Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: An international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences